Anti-retroviral Protease Inhibitors Market to Reach Expected Growth of CAGR 7.5% by 2037
The Anti-retroviral Protease Inhibitors Market has seen significant growth due to the increasing prevalence of HIV/AIDS and Hepatitis C, alongside advancements in drug formulations. The market, estimated at USD 3.7 billion in 2024, is expected to reach USD 7.3 billion by 2037, reflecting a compound annual growth rate (CAGR) of 7.5% over the forecast period. This growth is driven by global demand for more effective, cost-efficient treatments.
Anti-retroviral Protease Inhibitors Industry Demand
